drugset
drugset / Trial / NCT05432843

Comparing Pregabalin and Placebo in Patients With Persistent Globus Sensation

NCT05432843 ↗

Phase 4 Unknown 90 enrolled Universitaire Ziekenhuizen KU Leuven
RandomizedParallel-groupTriple-blindTreatment

Summary

To evaluate the relative merits, safety and effectiveness of pregabalin in globus patients compared with placebo.

Timeline

Start
2010-03-12
Primary completion
2023-01
Completion
2023-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pregabalin Small molecule 150 mg —

Indications

No indication recorded.